Nuvation Bio

Nuvation Bio

Pharmaceutical Manufacturing

New York, NY 4,699 followers

Nuvation Bio is focused on treating the most difficult-to-treat cancers, for which conventional therapies have failed.

About us

Nuvation Bio is a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai.

Website
http://www.nuvationbio.com
Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
New York, NY
Type
Public Company
Founded
2018

Locations

Employees at Nuvation Bio

Updates

Similar pages

Browse jobs

Funding